Pioneering Engineered Macrophages in Oncology & Beyond

Time: 1:30 pm
day: Post-Conference Solid Tumor Focus Day

Details:

• Exploring CAR-M platform for solid tumor immunotherapy
• Reviewing the clinical program overview of Anti-HER2 CAR-M ex vivo cell therapy
• Utilizing direct in vivo CAR reprogramming for oncology and other disease areas

Speakers:

Thomas Condamine